Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QGLY - Funny Name Great Product. -- Ignore unavailable to you. Want to Upgrade?

To: Will Preska who wrote (8652)	12/7/1998 1:04:00 PM
From: drakes353	Read Replies (1) \| Respond to of 8960

Will: OK, since you acknowledge the different ZIGG dosages between CE and what was used in the study, I'll take the "I'm sorry" as an admission of your incorrectness, and as an apology. Thanks. I'm firmly in the "it's the first study that was flawed" camp. The fact that the second study showed that zinc didn't work at reduced levels is logical since I'm of the opinion that no level of zinc "works". drakes353 PS: Take a look at the abcnews.com article....that UVA guy remains unimpressed with zinc. archive.abcnews.com